Combining principles from biology, engineering, and materials science, bioprinting and biofabrication are reshaping how complex tissues and organ structures are built. Through layer-by-layer deposition of living cells, biocompatible matrices, and growth factors, researchers can now create functional constructs that closely replicate native tissue architecture. The precision of 3D bioprinting technologies enables the spatial placement of multiple cell types, allowing intricate vascular networks and heterogeneous structures to emerge. Biofabrication strategies extend beyond printing to include self-assembly and mold-based techniques, enabling broader application in regenerative medicine and disease modeling. With developments in printable bioinks, bioreactor design, and imaging-guided fabrication, the potential for producing patient-specific grafts is becoming more realistic. Bioprinting and biofabrication are also facilitating high-throughput drug testing by offering physiologically relevant tissue models, reducing reliance on animal studies. The integration of computational design and real-time monitoring systems further enhances construct fidelity, paving the way for transformative clinical interventions.
Title : The era of artificial intelligence (AI) and its use in regenerative medicine
Vasiliki E Kalodimou, European University-Cyprus Ltd, Cyprus
Title : AI-integrated high-throughput tissue-chip for space-based biomanufacturing applications
Kunal Mitra, Florida Tech, United States
Title : Stem cells for human disease modelling and potential for tissue repair
Patrizia Ferretti, UCL Great Ormond Street Institute of Child Health, United Kingdom
Title : Advanced 3D tissue models: Pioneering tools for investigating health and disease
Lucie Bacakova, Institute of Physiology of the Czech Academy of Sciences, Czech Republic
Title : The role of gingival fibroblasts in periodontal diseases and regeneration
Katarzyna Gawron, Medical University of Silesia in Katowice, Poland
Title : Personalized and Precision Medicine (PPM): A unique healthcare model via pathology-related modelling and bi-odesign-inspired translational applications for the next gen-eration of human healthcare and biosafety
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation